Home › Research › NICE UK

NICE evidence review (2020): the evidence was very low — and was ignored for four years

Before the Cass Review, there was the NICE evidence review. In 2020, the British National Institute for Health and Care Excellence examined the evidence for puberty blockers and cross-sex hormones in children. The conclusion was devastating: very low quality of evidence, no convincing effects, and high risks of bias. NICE is an institute with global authority in evidence-based medicine — and was kept away from the policy debate by the affirmative action field for four years. Only Cass forced this recognition.

What NICE did

NICE — a leader in evidence-based medicine — conducted a systematic review at the request of the NHS. Two separate reports: one on puberty blockers, one on masculinizing/feminizing hormones in children. Standard methodology, public, replicable. Not an "activist" review — literally the same institute that reviews oncology and cardiology guidelines.

Key conclusions — puberty blockers

• All 9 included studies had a very high risk of bias.
• Quality of the evidence: very low according to GRADE.
• No convincing improvement in psychological functioning or well-being.
• No convincing reduction in suicidality.
• No convincing evidence that blockers reduce gender dysphoria.

Key conclusions — cross-sex hormones

• Evidence is also of very low quality.
• Short follow-up, no control groups, high dropout rate.
• Irreversible effects are not weighed against unproven benefits.

What it yielded — and what it did not yield

The NICE reviews were a direct trigger for the NHS assignment to Hilary Cass. What NICE established in 2020, the Cass Review confirmed in 2024 — only even more thoroughly. The signal was therefore already there in 2020, but was dismissed for years by the affirmative field as "transphobic" or "incomplete". For four years, blockers and hormones entered British children's bodies while the evidence had already been declared non-existent by the country's highest evidence authority. That is not a scientific accident — that is institutional resistance to the facts.

Comparison with other systematic reviews

The NICE conclusions fully overlap with those of SBU (Sweden 2022) , COHERE (Finland 2020) , and Ukom (Norway 2023) . Not a single systematic review adhering to GRADE reaches a favorable verdict — only activist reviews that abandon methodology or avoid evidence tables, such as WPATH itself (see WPATH Files ). Four evidence bodies, one conclusion.